🔗 Share this article

Acclaimed soul vocalist D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The shining star of our family has faded away for us in this life,” his family confirmed. “After a lengthy and courageous struggle with cancer, we are deeply saddened to announce that D’Angelo, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his innovative neo-soul sound and partnerships with high-profile artists.

He launched his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album achieved No. 4 on Billboard’s Top R&B Albums chart, went platinum soon after, and earned multiple award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his artistic journey into the limelight. The album debuted at the top spot on both Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammys: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a reluctant one, in the cultural zeitgeist. The personal depiction showed the singer, famously stripped down to his waist, singing directly into the lens.

D’Angelo stepped back from the spotlight after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was involved in a severe car crash that left him in grave health.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his lasting popularity with a further top chart entry on the R&B chart and a Grammy for Top R&B Record.

Again, in his own mysterious way, D’Angelo had limited public outings in the subsequent period.

The musician was announced as a top act for the 2025 music event, but his performance was called off, citing an “unforeseen medical delay.”

Although information is limited about D’Angelo’s health in the weeks before his passing, he had reportedly been hospitalized for an extended period and in palliative care for two weeks.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic malignancy, one of the deadliest and least preventable forms of the disease, on a brilliant talent whose life was cut short.

“We are grieved that he can only provide cherished moments with his family, but we are eternally grateful for the heritage of extraordinarily moving songs he has left us,” his family expressed.

Pancreatic Cancer: Deadly and Rarely Preventable

Pancreatic malignancy impacts the digestive organ, a small organ that produces the hormone insulin and is vital in digestion, among other functions. The size and location of the pancreas in the body make it more challenging to detect malignancy.

Even though this cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is responsible for 7% of cancer deaths.

Almost seventy thousand people will be diagnosed with this condition and roughly 52,000 will succumb to the disease in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have few and poor therapies, and a narrow opportunity to make a meaningful impact on the lives of patients,” said a medical oncologist.

Since this disease seldom produces initial signs, it’s often diagnosed only after the disease is late-stage. Even when a patient has symptoms they are usually vague and may be mistaken for a several everyday ailments.

“Currently, there is no effective method to identify this malignancy in the early stages, except for listening to your body and speaking with your physician if there are unfamiliar symptoms,” explained a medical director.

Frequent indicators of pancreatic cancer encompass:

• discomfort in the stomach or back
• reduced body mass
• yellowing of skin and eyes
• reduced hunger
• dark urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in individuals in the sixty-five to seventy-five range. However, numerous malignancies, including pancreatic cancer, have become more common in younger adults.

“Pancreatic cancer diagnosed prior to fifty is considered rare, yet concerningly, clinicians are noticing a growing number of younger individuals affected by this disease,” said a specialist.

Family History Impacts Cancer Risk

In the absence of effective screening tools for pancreatic cancer, professionals stressed the importance of knowing your family’s cancer history. Some risk factors, such as tobacco use and excess weight also play a role in the onset of pancreatic cancer.

Black individuals have the highest incidence of pancreatic cancer in the United States and are most likely to be found to have inoperable cancer.

“The initial action toward lowering one’s chance of this condition is understanding individual susceptibility. People should review their genetic background, genetic background, and health issues, such as blood sugar disease, chronic pancreatitis, or obesity that may increase their vulnerability,” said a medical professional.

Hereditary risk factors are linked to as much as ten percent of all pancreatic cancer cases. If a relative in your family has had this disease, you may want to think about DNA analysis.

“For individuals with a family history of pancreatic cancer or those carrying high risk DNA changes, screening may involve sophisticated scans such as MRI scans or internal ultrasound to detect early changes in the organ,” he clarified.

For those looking to reduce their risk, habit adjustments may make a difference. The best action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you are a non-smoker, avoid exposure altogether.

Heavy alcohol consumption is linked to pancreas inflammation, a risk factor for this malignancy, so limiting or avoiding alcohol may assist lower your chance.

Controlling your body mass or losing weight may also aid decrease your susceptibility. Individuals with obesity are 20% more likely to develop pancreatic cancer. This malignancy also occurs more often in those with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is still hope.

“We are doing better with treatments and more recent combination chemotherapy. There are emerging precision medicines that are already showing results,” remarked a expert.

For many people, however, education about this uncommon but {dev